S&P Futures
3,832.25 +6.75 (+0.18%) Dow Futures
30,975.00 +42.00 (+0.14%) Nasdaq Futures
11,710.25 +36.00 (+0.31%) Russell 2000 Futures
1,741.40 +3.10 (+0.18%) Crude Oil
111.16 -0.60 (-0.54%) Gold
1,822.00 +0.80 (+0.04%)
Matinas BioPharma Holdings, Inc. (MTNB)
After hours:
Chart Events
Performance Outlook
| Previous Close | 0.8099 |
| Open | 0.7999 |
| Bid | 0.0000 x 1300 |
| Ask | 0.0000 x 800 |
| Day's Range | 0.7900 - 0.8300 |
| 52 Week Range | 0.4900 - 1.6100 |
| Volume | |
| Avg. Volume | 549,470 |
| Market Cap | 177.323M |
| Beta (5Y Monthly) | 2.22 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1140 |
| Earnings Date | Mar 28, 2022 - Apr 01, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.75 |
- Insider Monkey
10 Best Biotech Penny Stocks To Buy Now
In this article, we discuss the 10 best biotech penny stocks to buy now. If you want to skip our detailed analysis of the biotech sector, go directly to 5 Best Biotech Penny Stocks To Buy Now. Like all sectors of the economy right now, the biotech sector is going through a lot of pain. The […]
- GlobeNewswire
Matinas BioPharma to Present at the LD Micro Invitational XII Conference
BEDMINSTER, N.J., May 31, 2022 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on improving the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (LNC) platform technology, announced today that Jerry Jabbour, Chief Executive Officer, has been invited to present at the LD Micro Invitational XII Conference on Tuesday, June 7, 2022, at 3:30 p.m. ET (12:30 p.m. PT). The conference is being held at the Fo
- Zacks
Matinas Biopharma Holdings, Inc. (MTNB) Reports Q1 Loss, Misses Revenue Estimates
Matinas Biopharma Holdings, Inc. (MTNB) delivered earnings and revenue surprises of 0% and 100%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
